[一种新型合成化合物（3-烟酰氧基丙基对氯苯氧基异丁酸酯：I.612）对IIa型、IIb型和IV型高脂血症患者血脂的影响] - Suppr | 超能文献

[Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].

作者信息

Bucalossi A, Buzzelli G, D'Alessandro A

出版信息

Clin Ter. 1979 Apr 30;89(2):127-49.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].[一种新型合成化合物（3-烟酰氧基丙基对氯苯氧基异丁酸酯：I.612）对IIa型、IIb型和IV型高脂血症患者血脂的影响]

Clin Ter. 1979 Apr 30;89(2):127-49.

2

Clofibrate and related compounds in hyperlipoproteinaemia. A review.氯贝丁酯及相关化合物治疗高脂蛋白血症。综述。

Postgrad Med J. 1975;51(8):suppl 66-71.

3

Effect of hypolipidemic drugs on serum lipoproteins.降血脂药物对血清脂蛋白的影响。

Prog Biochem Pharmacol. 1979;15:238-57.

4

Treatment of hyperlipidemia.高脂血症的治疗。

N Engl J Med. 1974 Jun 6;290(23):1295-301. doi: 10.1056/NEJM197406062902306.

5

[Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].[α-甲基甲状腺素（司克洛诺姆）与氯贝丁酯（利占隆）对IIa/b型和IV型高脂蛋白血症患者降低胆固醇及甘油三酯作用的比较研究]

Verh Dtsch Ges Inn Med. 1977;83:392-5.

6

Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).抗脂药物。第5部分：LF 178对191例患致动脉粥样硬化型内源性高脂蛋白血症（IIa型、IIb型和IV型）患者的降血脂作用评估。

Arzneimittelforschung. 1976;26(5):901-6.

7

[Preliminary study of the tolerance of 3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate (I. 612) and on its effects on plasma lipid pattern, hemostasis and clotting-fibrinolysis balance].3-烟酰氧基丙基对氯苯氧异丁酸酯（I. 612）耐受性及其对血脂谱、止血和凝血-纤溶平衡影响的初步研究

Clin Ter. 1979 May 15;89(3):251-66.

8

A physician's guide to hyperlipidemia.高脂血症医生指南

Mod Concepts Cardiovasc Dis. 1972 Jul;41(7):31-6.

9

Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.在双盲条件下进行的普拉贝特降血脂和抗血小板聚集活性的临床研究，并与氯贝丁酯作比较。

Arzneimittelforschung. 1981;31(10a):1863-6.

10

[Current trends in the therapy of arteriosclerotic disease].[动脉硬化性疾病治疗的当前趋势]

G Clin Med. 1974 Jan;55(1):27-39.